Interaction of curcumin with lipid monolayers and liposomal bilayers

Colloids and Surfaces B: Biointerfaces

Volumn 88, Issue 1, 2011, Pages 231-239

  Karewicz, Anna ^a   Bielska, Dorota ^a   Gzyl Malcher, Barbara ^a   Kepczynski, Mariusz ^a   Lach, Radosław ^b   Nowakowska, Maria ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

Author keywords

Curcumin; Fluorescence; Langmuir monolayer; Liposomes

Indexed keywords

ANTI-INFLAMMATORY AGENTS; BALANCE MEASUREMENT; BI-LAYER; BINDING CONSTANT; CURCUMIN; DIHEXADECYL PHOSPHATE; DRUG LOADING; EGG YOLK PHOSPHATIDYLCHOLINE; FLUORESCENCE MEASUREMENTS; FLUORESCENCE QUENCHING; HYDROPHOBIC REGIONS; LANGMUIR MONOLAYERS; LANGMUIRS; LIPID COMPOSITION; LIPID MEMBRANES; LIPID MONOLAYER; MIXED MONOLAYERS; MIXED SYSTEMS; MONOLAYER SYSTEM; THREE-COMPONENT;

BIOCHEMISTRY; CELL MEMBRANES; CYTOLOGY; FLUORESCENCE; LIPOSOMES; MONOLAYERS; PHOSPHOLIPIDS;

LIPID BILAYERS;

CURCUMIN; LIPID; LIPOSOME;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG STABILITY; FLUORESCENCE ANALYSIS; LANGMUIR BLODGETT FILM; LIPID BILAYER; LIPID COMPOSITION; LIPID MEMBRANE; LIPOSOMAL DELIVERY; MOLECULAR INTERACTION; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; ULTRAVIOLET SPECTROSCOPY;

CHOLESTEROL; CURCUMIN; EGG YOLK; LIPID BILAYERS; LIPOSOMES; PHOSPHATIDYLCHOLINES; SPECTROMETRY, FLUORESCENCE;

EID: 80052096116     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.06.037     Document Type: Article

References (34)

1. Shishodia S., Singh T., Chaturvedi M.M. Modulation of transcription factors by curcumin. Adv. Exp. Med. Biol. 2007, 595:127.
2. Yoysungnoen P., Wirachwong P., Bhattarakosol P., Niimi H., Patumraj S. Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin. Hemorheol. Micro. 2006, 34:109.
3. Sahu R.P., Batra S., Srivastava S.K. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Brit. J. Cancer 2009, 100:1425.
4. Plummer S.M., Holloway K.A., Manson M.M., Munks R.J., Kaptein A., Farrow S., Howells L. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 1999, 18:6013.
5. Karunagaran D., Rashmi R., Kumar T.R. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr. Cancer Drug Targets 2005, 5:117.
6. Watson J.L., Hill R., Yaffe P.B., Greenshields A., Walsh M., Lee P.W., Giacomantonio C.A., Hoskin D.W. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Lett. 2010, 297:1.
7. Tharakan B., Hunter F.A., Smythe W.R., Childs E.W. Curcumin inhibits reactive oxygen species formation and vascular hyperpermeability following haemorrhagic shock. Clin. Exp. Pharmacol. Physiol. 2010, 37:939.
8. Zhang F., Altorki N.K., Mestre J.R., Subbaramaiah K., Dannenberg A.J. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 1999, 20:445.
9. Wang Y.-J., Pan M.-H., Cheng A.-L., Lin L.-I., Ho Y.-S., Hsieh C.-Y., Lin J.-K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 1997, 15:1867-1876.
10. Li L., Braiteh F.S., Kurzrock R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005, 104:1322.
11. Narayanan N.K., Nargi D., Randolph C., Narayanan B.A. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int. J. Cancer 2009, 125:1.
12. Kunwar A., Barik A., Pandey R., Priyadarsini K.I. Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study. Biochim. Biophys. Acta Gen. Subj. 2006, 1760:1513.
13. Sun Y., Lee Ch.-Ch., Hung W.-Ch., Chen F.-Y., Lee M.-T., Huang H.W. The bound states of amphipathic drugs in lipid bilayers: study of curcumin. Biophys. J. 2008, 95:2318.
14. Benesi H., Hildebrand J. A spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. J. Am. Chem. Soc. 1949, 71:2703.
15. Ke{ogonek}pczyński M., Pandian R.P., Smith K.M., Ehrenberg B. Do liposome-binding constants of porphyrins correlate with their measured and predicted partitioning between octanol and water?. Photochem. Photobiol. 2002, 76:127.
16. Exner O. Calculating equilibrium constant from spectral data: reliability of the Benesi-Hildebrand method and its modifications. Chemom. Intell. Lab. Syst. 1997, 39:85.
17. Subczynski W.K., Wisniewska A., Yin J.-J., Hyde J.S., Kusumi A. Hydrophobic barriers of lipid bilayer membranes formed by reduction of water penetration by alkyl chain unsaturation and cholesterol. Biochemistry 1994, 33:7670.
18. Ke{ogonek}pczyński M., Karewicz A., Górnicki A., Nowakowska M. Interactions of porphyrin covalently attached to poly(methacrylic acid) with liposomal membranes. J. Phys. Chem. B 2005, 109:1289.
19. Blatt E., Sawyer W.H. Depth-dependent fluorescent quenching in micelles and membranes. Biochim. Biophys. Acta Biomembr. 1985, 822:43.
20. Van Esch J.H., Feiters M.C., Peters A.M., Nolte J.M. UV-Vis, fluorescence, and EPR studies of porphyrins in bilayers of dioctadecyldimethylammonium surfactants. J. Phys. Chem. 1994, 98:5541.
21. Steiner R.F. Topics in fluorescence spectroscopy. Principles 1991, vol. 2. Plenum, New York, (Chapter 1).
22. Ke{ogonek}pczyński M., Kumorek M., Stepniewski M., Róg T., Kozik B., Jamróz D., Bednar J., Nowakowska M. Behavior of 2,6-bis(decyloxy)naphthalene inside lipid bilayer. J. Phys. Chem. B 2010, 114:15483.
23. Hernandez-Borrell J., Mas F., Puy J. A theoretical approach to describe monolayer-liposome lipid interaction. Biophys. Chem. 1990, 36:47.
24. Peetla Ch., Stine A., Labhasetwar V. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol. Pharm. 2009, 6:1264.
25. Gzyl B., Filek M., Dudek A. Biophysical interactions with model lipid membranes: Applications in drug discovery and drug delivery. J. Colloid Interface Sci. 2004, 269:153.
26. Davies J.T., Rideal E.K. Interfacial Phenomena 1963, Academic Press, New York.
27. Birdi K.S. Lipid and Biopolymer Monolayers at Liquid Interfaces 1989, John Wiley & Sons, New York.
28. Barry J., Fritz M., Brender J.R., Smith P.E.S., Lee D-K., Ramamoorthy A. Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin. J. Am. Chem. Soc. 2009, 131:4490.
29. Ingolfsson H.I., Koeppe R.E., Andersen O.S. Curcumin is a modulator of bilayer material properties. Biochemistry 2007, 46:10384.
30. Semple S.C., Chonn A., Cullis P.R. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry 1996, 35:2521.
31. Mortara R.A., Quina F.H., Chaimovich H. Formation of closed vesicles from a simple phosphate diester. Preparation and some properties of vesicles of dihexadecyl phosphate. Biochem. Biophys. Res. Commun. 1978, 81:1080.
32. Gustafsson J., Oradd G., Almgren M. Disintegration of thelecithin lamellar phase by cationic surfactants. Langmuir 1997, 13:6956.
33. De la Maza A., Parra J.L. Vesicle-micelle structural transitions of phospholipid bilayers and sodium dodecyl sulfate. Langmuir 1995, 11:2435.
34. Yaroslavov A.A., Kiseliova E.A., Udalykh O.Yu., Kabanov V.A. Integrity of mixed liposomes contacting a polycation depends on the negatively charged lipid content. Langmuir 1998, 14:5160.